Found 6 matching trials
VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer PHASE1 This is a nonrandomized, open phase I dose escalation and extension clinica...
Show More Learn More & Join Trial
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation PHASE1 This is a single-arm, phase I/II, study of PTCy/sirolimus plus VIC-1911 to ...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC NA This study is a single-arm, open-label trial to clarify the safety and effi...
Show More Status
Active Not Recruiting
Location
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Learn More & Join Trial
A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children PHASE1 This study is a single arm, open label Phase Ib clinical trial, consisting ...
Show More Location
Multiple Locations
Learn More & Join Trial
VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer PHASE1 This is a Phase 1a/1b study of aurora kinase A inhibitor VIC-1911 administe...
Show More Location
University of California Davis
Learn More & Join Trial
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC NA This is a prospective clinical study aiming to test the safety and efficacy...
Show More Location
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Learn More & Join Trial